

The Rundown
Public.com
Daily stock market update in under 10 minutes. Stay up to date with the companies making the biggest moves and learn about the economic news that can help you be a better investor. Hosted by Zaid Admani. Created by Public.com.
Episodes
Mentioned books

8 snips
Dec 27, 2025 • 13min
Deep Dive: 4 Space Stocks to Watch as SpaceX Nears IPO
The space economy is heating up, driven by the buzz around SpaceX’s potential IPO. There’s a fascination with investing in companies aligned with this cosmic race. Topics include the potential of AI data centers in orbit and the U.S. government’s renewed commitment to space exploration. Companies like EchoStar and Rocket Lab are discussed for their connections to SpaceX and satellite innovations. However, there's caution amid the hype, as the market navigates risks and attempts to identify long-term winners.

10 snips
Dec 26, 2025 • 10min
Nvidia's Shocking $20B Deal with Chip Startup Groq, Silver & Gold Surge to New Records
Nvidia stuns the market with a $20B deal for AI chip company Groq, shaking up competition. Gold and silver prices reach historic highs, fueled by geopolitical tensions and increased demand. Memory chip stocks also surge due to AI-driven price hikes. In a somber twist, Biohaven faces a significant drop after its depression drug trial fails. Plus, discover how Coca-Cola influenced the modern image of Santa Claus in a nostalgic look back.

Dec 24, 2025 • 9min
Tim Cook Buys $3M of Nike Stock, AI Fleet Company Motive Files for IPO
The S&P 500 hits new records as GDP growth outpaces expectations. Tim Cook makes waves by investing $3M in struggling Nike stock. Exciting news from the AI sector as Motive files for an IPO, showcasing a unique approach to fleet management. Meanwhile, Dynavax experiences a boost after a $2.2B acquisition by Sanofi. On the flip side, Intel faces challenges as NVIDIA shuns its manufacturing process, adding to the woes of tech IPOs in 2025, with most trading below their initial prices.

Dec 23, 2025 • 10min
Novo Nordisk Wins FDA Approval for Weight-Loss Pill, Alphabet Buys Clean Energy Provider
Gold and silver prices soar as investors hedge against future uncertainty. Novo Nordisk celebrates FDA approval for its weight-loss pill, WeGovie, creating waves in the market. Google enhances its clean energy portfolio by acquiring a renewable energy firm for $4.75 billion, aiming to support AI growth. Meanwhile, U.S. drone manufacturers thrive after a ban on foreign competitors, and Johnson & Johnson faces a $1.5 billion verdict related to its baby powder. All this and more keeps the financial landscape buzzing!

Dec 22, 2025 • 9min
Larry Ellison Backs Paramount’s Bid for WBD, Nvidia to Ship H200 Chips to China by February
Investors are watching for a Santa Claus rally as the year wraps up. Larry Ellison's $40 billion guarantee boosts Paramount's bid for WBD. NVIDIA plans to restart shipments of its H200 AI chips to China, igniting demand. Rocket Lab celebrates landing its largest contract ever, worth $816 million. Meanwhile, Honeywell faces a hefty $470 million settlement from litigation. Lastly, the new Avatar movie saw a disappointing box office start despite strong international interest.

8 snips
Dec 21, 2025 • 28min
Why Tariffs Haven't Tanked the Economy (ft. Justin Wolfers)
Justin Wolfers, Professor of Public Policy and Economics at the University of Michigan, discusses crucial topics surrounding the Federal Reserve's decisions and tariffs. He explains the significance of growing dissent at the Fed and how it impacts market perceptions. The conversation highlights the differences between cost-driven and demand-driven inflation, emphasizing the unique effects on households. Wolfers also critiques current policies affecting affordability and suggests reforms for improving living standards.

9 snips
Dec 20, 2025 • 10min
Deep Dive: Is Medline the Costco of Healthcare? Inside the Biggest IPO of 2025
Explore the massive IPO of Medline, a lesser-known medical-supply giant, which recently surpassed high-profile names like Circle and Klarna. Discover why its CEO likens it to the 'Costco of Healthcare,' diving into its membership model and product breadth. Learn about its impressive revenue growth and strong customer retention. The discussion also addresses potential investment risks, including heavy debt and margin concerns, while offering insight into Medline's unique distribution network and self-manufacturing capabilities.

8 snips
Dec 19, 2025 • 10min
Nike Tanks After Warning of Sales Drop, TikTok Signs Deal for U.S. Joint Venture
Analysts express skepticism over inflation data as Nike posts strong earnings yet forecasts weaker sales due to margin pressures. TikTok inches closer to a U.S. joint venture with Oracle, navigating complex regulatory waters. Meanwhile, CoreWeave joins the federal government's AI Genesis mission, boosting its stock. In a surprising twist, NVIDIA, now a tech giant, replaced Enron in the S&P 500 back in 2001, highlighting its incredible stock journey. Tune in for these insights and more!

11 snips
Dec 18, 2025 • 10min
Netflix Goes All-In on Podcasts, Instacart Probed by FTC for AI Pricing Tool
The discussion kicks off with a surprising market dip linked to AI concerns at Oracle. Next, a cooler-than-expected CPI hints at potential Federal Reserve rate cuts in 2026. Netflix is making waves with its ambitious foray into podcasts, launching exclusive deals while also vying for attention in the gaming space with a casual FIFA game. Meanwhile, Instacart faces scrutiny from the FTC over dynamic pricing practices, raising eyebrows in the industry. The episode wraps up with insights into Micron's strong memory demand and Elliott's bold stake in Lululemon.

16 snips
Dec 17, 2025 • 10min
WBD Rejects Paramount Bid, Amazon in Talks to Invest $10B in OpenAI
Warner Bros. Discovery has turned down a $30 billion bid from Paramount, opting for a deal with Netflix instead. Meanwhile, Amazon is in talks to invest over $10 billion in OpenAI, hinting at a massive valuation for the AI company. DBV Technologies celebrates a successful trial for its peanut allergy treatment, while housing giant Lennar faces challenges with declining profits. Lastly, Waymo has reached a staggering valuation of $100 billion, signaling exciting potential in the tech market.


